Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma

Clinical and Experimental Allergy

Volumn 34, Issue 2, 2004, Pages 276-284

  Lee, K S ^a   Jin, S M ^a   Lee, H ^a   Lee, Y C ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Jeonbuk National University Medical School and Hospital   (South Korea)

Author keywords

Airway remodelling; Matrix metalloproteinase 9; Neutrophils; Occupational asthma; Tissue inhibitor of metalloproteinase 1

Indexed keywords

GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLUENE DIISOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BIOACCUMULATION; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOLOGY; EOSINOPHIL; EXPERIMENTAL MODEL; FEMALE; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LUNG PARENCHYMA; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OCCUPATIONAL DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLVENTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOLUENE 2,4-DIISOCYANATE;

EID: 1542375247     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01849.x     Document Type: Article

References (34)

1. Delacourt C, Le Bourgeois M, D'Orho MP et al. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152:765-74.
2. Hayashi T, Stetler-Stevenson WG, Fleming MV et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149:1241-56.
3. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM. Matrix metalloproteinase and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:346-52.
4. Sepeer R, Konttinen YT, Ding Y, Takagi M, Sorsa T. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 1995; 107:1641-7.
5. Nagase H. Activation mechanisms of matrix metalloproteinases. J Biol Chem 1997; 378:151-60.
6. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7:728-35.
7. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane component in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17:519-28.
8. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995; 154:4379-89.
9. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14:288-95.
10. Vignola AM, Riccobono L, Mirabella A et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airway obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:1945-50.
11. Hoshino M, Takahashi M, Takai Y, Sim JJ. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104:356-64.
12. Bousquet J, Chanez P, Lacoste JY et al. Asthma: a disease remodeling the airways. Allergy 1992; 47:3-11.
13. Chan-Yeung M. Occupational asthma. Chest 1999; 98:148S-61S.
14. Park HS, Nahm DH. Isocyanate-induced occupational asthma: challenge and immunologic studies. J Korean Med Sci 1996; 11:314-8.
15. Bernstein IL. Isocyanate-induced pulmonary diseases: a current perspective. J Allergy Clin Immunol 1982; 70:24-31.
16. Vandenplas O, Cartier A, Ghezzo H, Cloutier Y, Malo JL. Response to isocyanates: effect of concentration, duration of exposure, and dose. Am Rev Respir Dis 1993; 147:1287-90.
17. Scheerens H, Buckley TL, Muis T, Van Loveren H, Nijkamp FP. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br J Pharmacol 1996; 119:1665-71.
18. Raulf-Heimsoth M, Baur X. Pathomechanisms and pathophysiology of isocyanate-induced diseases - summary of present knowledge. Am J Ind Med 1998; 34:137-43.
19. Mapp CE, Saetta M, Maestrelli P et al. Mechanisms and pathology of occupational asthma. Eur Respir J 1994; 7:544-54.
20. Mapp CE, Boschetto P, Zocca E et al. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates. Bull Eur Physiopathol Respir 1987; 23:583-6.
21. Boschetto P, Fabbri LM, Zocca E et al. Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol 1987; 80:261-7.
22. Lee YC, Song CH, Lee HB et al. A murine model of toluene diisocyanate induced asthma can be treated with matrix metalloproteinase inhibitor. J Allergy Clin Immunol 2001; 108:1021-6.
23. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyper-responsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 2002; 168:3595-600.
24. Scheerens H, Buckley TL, Muis TL et al. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 1999; 159:1074-80.
25. Hamelmann E, Schwarze J, Takeda K et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-75.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
27. Wilson JW, Li X, Pain MC. The lack of distensibility of asthmatic airways. Am Rev Respir Dis 1993; 148:806-9.
28. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG. Neutral proteinases of human mononuclear phagocytes: cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol 1991; 146:1286-93.
29. Ohno I, Ohtani H, Nitta Y et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16:212-9.
30. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7:120-5.
31. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 1989; 264:17374-8.
32. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 1989; 86:8207-11.
33. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286-92.
34. Park HS, Cho SH, Hong CS, Kim YY. Isocyanate-induced occupational asthma in far-east Asia: pathogenesis to prognosis. Clin Exp Allergy 2002; 32:198-204.